Vicore Pharma Holding AB (VCRE) Price Prediction & ForecastVCREForecastVicore Pharma Holding AB

Vicore Pharma Holding AB (VCRE) is not a good buy right now due to its significant negative performance and weak technical indicators. The stock has a current price of 11.31, with a year-to-date change of -30.40%, indicating a substantial decline. Additionally, the RSI is at 40.642, suggesting the stock is nearing oversold territory but not yet at a strong buy signal. The forward P/E ratio is 0, indicating no earnings growth expectations, which raises concerns about its future profitability. The main risk is its negative price-to-earnings ratio of -0.66, indicating the company is currently unprofitable. Overall, the combination of declining performance and lack of positive catalysts makes this stock a sell.

Vicore Pharma Holding AB (VCRE) last closed at $11.31, gaining +1.53%. These facts feed the 1-day and 1-week VCRE price prediction above.